share_log

中国生物制药(01177.HK)拟3月28日举行董事会会议批准年度业绩

China Biopharmaceutical (01177.HK) plans to hold a board meeting on March 28 to approve annual results

Gelonghui Finance ·  Mar 1 03:39

Gelonghui, March 1, 丨 China Biopharmaceutical (01177.HK) announced that the company will hold a board meeting on March 28, 2024 (Thursday) to approve (among other things) the publication of the annual results of the company and its subsidiaries for the year ended 31 December 2023 and consider the proposed payment of a final dividend (if any).

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment